These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36380221)

  • 1. The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia.
    Moya NA; Yun S; Fleps SW; Martin MM; Nadel JA; Beutler LR; Zweifel LS; Parker JG
    Neuropsychopharmacology; 2023 Mar; 48(4):690-699. PubMed ID: 36380221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist.
    Natesan S; Reckless GE; Barlow KB; Odontiadis J; Nobrega JN; Baker GB; George SR; Mamo D; Kapur S
    Psychopharmacology (Berl); 2008 Aug; 199(2):275-89. PubMed ID: 18521575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Gill KM; Cook JM; Poe MM; Grace AA
    Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity.
    Charron A; Hage CE; Servonnet A; Samaha AN
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2381-93. PubMed ID: 26508706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced presynaptic dopamine activity in adolescent dorsal striatum.
    Matthews M; Bondi C; Torres G; Moghaddam B
    Neuropsychopharmacology; 2013 Jun; 38(7):1344-51. PubMed ID: 23358239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype.
    Pitychoutis PM; Belmer A; Moutkine I; Adrien J; Maroteaux L
    Neuropsychopharmacology; 2015 Nov; 40(12):2764-73. PubMed ID: 25936642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of TAK-071, a muscarinic M
    Kurimoto E; Yamada R; Hirakawa T; Kimura H
    Neurosci Lett; 2021 Nov; 764():136240. PubMed ID: 34509568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of schizophrenia.
    Jones CA; Watson DJ; Fone KC
    Br J Pharmacol; 2011 Oct; 164(4):1162-94. PubMed ID: 21449915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol-induced Nur77 expression in striatopallidal neurons is under the control of protein phosphatase 1 regulation by DARPP-32.
    Sánchez N; Coura R; Engmann O; Marion-Poll L; Longueville S; Hervé D; Andrés ME; Girault JA
    Neuropharmacology; 2014 Apr; 79():559-66. PubMed ID: 24440754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia.
    Xiberas X; Martinot JL; Mallet L; Artiges E; Loc'H C; Mazière B; Paillère-Martinot ML
    Br J Psychiatry; 2001 Dec; 179():503-8. PubMed ID: 11731352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia.
    Talpos J; Aerts N; Waddell J; Steckler T
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3911-20. PubMed ID: 25902874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with D2-antagonist haloperidol leads to inhibitory/excitatory imbalance in striatal D1-neurons.
    Santa C; Rodrigues D; Coelho JF; Anjo SI; Mendes VM; Bessa-Neto D; Dunn MJ; Cotter D; Baltazar G; Monteiro P; Manadas B
    Transl Psychiatry; 2023 Oct; 13(1):312. PubMed ID: 37803004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia.
    Lapish CC; Ahn KC; Chambers RA; Ashby DM; Ahn S; Phillips AG
    Neuropsychopharmacology; 2014 Jun; 39(7):1754-62. PubMed ID: 24476944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
    Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY
    Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine.
    Fischer KD; Houston ACW; Desai RI; Doyle MR; Bergman J; Mian M; Mannix R; Sulzer DL; Choi SJ; Mosharov EV; Hodgson NW; Bechtholt A; Miczek KA; Rosenberg PA
    Psychopharmacology (Berl); 2018 May; 235(5):1371-1387. PubMed ID: 29468294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
    El Hage C; Bédard AM; Samaha AN
    Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol.
    Millan MJ; Schreiber R; Dekeyne A; Rivet JM; Bervoets K; Mavridis M; Sebban C; Maurel-Remy S; Newman-Tancredi A; Spedding M; Muller O; Lavielle G; Brocco M
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1356-73. PubMed ID: 9732399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.